Cargando…

Changes in Lipidomics, Metabolomics, and the Gut Microbiota in CDAA-Induced NAFLD Mice after Polyene Phosphatidylcholine Treatment

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in most parts of the world. Although there is no first-line drug approved for the treatment of NAFLD, polyene phosphatidylcholine (PPC) is used by clinicians to treat NAFLD patients. This study aimed to evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiayuan, Zang, Xiaoling, Lv, Jinxiao, Zhang, Yicong, Lv, Zhihua, Yu, Mingming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862520/ https://www.ncbi.nlm.nih.gov/pubmed/36675016 http://dx.doi.org/10.3390/ijms24021502

Ejemplares similares

Effect of polyene phosphatidylcholine/ursodeoxycholic acid/ademetionine on pregnancy outcomes in intrahepatic cholestasis
por: Dong, Xiao-Rui, et al.
Publicado: (2023)

Alterations of Gut Microbiota and Blood Lipidome in Gestational Diabetes Mellitus With Hyperlipidemia
por: Liu, He, et al.
Publicado: (2019)

A Multicenter Real-World Study Evaluating the Hepatoprotective Effect of Polyene Phosphatidylcholine Against Chronic Hepatitis B
por: Xu, Jinghang, et al.
Publicado: (2022)

Plasma lipidomics of tuberculosis patients: altered phosphatidylcholine remodeling
por: Wood, Paul L, et al.
Publicado: (2017)

The Diadenylate Cyclase CdaA Is Critical for Borrelia turicatae Virulence and Physiology
por: Jackson-Litteken, Clay D., et al.
Publicado: (2021)

Polyene Phosphatidylcholine Ameliorates High Fat Diet-Induced Non-alcoholic Fatty Liver Disease via Remodeling Metabolism and Inflammation
por: Lu, Yang, et al.
Publicado: (2022)

Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome
por: Lovric, Alen, et al.
Publicado: (2018)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
por: Jiang, Xiaofan, et al.
Publicado: (2020)

Gut Microbiota and Lifestyle Interventions in NAFLD
por: Houghton, David, et al.
Publicado: (2016)

Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle
por: Valentine, William J., et al.
Publicado: (2022)

Gut Microbiota: Association with NAFLD and Metabolic Disturbances
por: Lau, E., et al.
Publicado: (2015)

Lipidomics Identified Lyso-Phosphatidylcholine and Phosphatidylethanolamine as Potential Biomarkers for Diagnosis of Laryngeal Cancer
por: Yu, Bo, et al.
Publicado: (2021)

Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison
por: Lei, Xiaohong, et al.
Publicado: (2021)

Computer-aided design of a cyclic di-AMP synthesizing enzyme CdaA inhibitor
por: Neumann, Piotr, et al.
Publicado: (2023)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
por: Moszak, Małgorzata, et al.
Publicado: (2021)

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
por: Hrncir, Tomas, et al.
Publicado: (2021)

Genealogy of Conjugated Acyclic Polyenes
por: Hosoya, Haruo
Publicado: (2017)

Lipidomic profiling in Crohn's disease: Abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine composition
por: Sewell, Gavin W., et al.
Publicado: (2012)

Characterization of Bulk Phosphatidylcholine Compositions in Human Plasma Using Side-Chain Resolving Lipidomics
por: Quell, Jan D., et al.
Publicado: (2019)

FACS-assisted single-cell lipidome analysis of phosphatidylcholines and sphingomyelins in cells of different lineages
por: Hancock, Sarah E., et al.
Publicado: (2023)

Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD
por: Li, Juan, et al.
Publicado: (2020)

Deficiency in Galectin-3 Promotes Hepatic Injury in CDAA Diet-Induced Nonalcoholic Fatty Liver Disease
por: Nomoto, Kazuhiro, et al.
Publicado: (2012)

Intracellular Concentrations of Borrelia burgdorferi Cyclic Di-AMP Are Not Changed by Altered Expression of the CdaA Synthase
por: Savage, Christina R., et al.
Publicado: (2015)

Lipidomic data uncover extensive heterogeneity in phosphatidylcholine structural variants in HepG2 cells
por: Chico, Yolanda, et al.
Publicado: (2019)

Lipidomic studies reveal two specific circulating phosphatidylcholines as surrogate biomarkers of the omega-3 index
por: Ly, Ritchie, et al.
Publicado: (2023)

CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
por: Ge, Haize, et al.
Publicado: (2022)

Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure
por: Rong, Jidong, et al.
Publicado: (2023)

Time-Restricted Feeding Modifies the Fecal Lipidome and the Gut Microbiota
por: Rust, Bret M., et al.
Publicado: (2023)

Structural basis for the inhibition of the Bacillus subtilis c-di-AMP cyclase CdaA by the phosphoglucomutase GlmM
por: Pathania, Monisha, et al.
Publicado: (2021)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Correlation Analysis of Gut Microbiota and Serum Metabolome With Porphyromonas gingivalis-Induced Metabolic Disorders
por: Dong, ZhengJie, et al.
Publicado: (2022)

Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii
por: Zhu, Shixing, et al.
Publicado: (2023)

Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance
por: Høeg, Tracy B., et al.
Publicado: (2020)

The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
por: Soderborg, Taylor K., et al.
Publicado: (2018)

The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota
por: Li, Xin, et al.
Publicado: (2019)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
por: Shi, Ameng, et al.
Publicado: (2021)

The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Integration of Lipidomics and Transcriptomics Reveals the Efficacy and Mechanism of Qige Decoction on NAFLD
por: Fan, Simin, et al.
Publicado: (2022)

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
por: Wang, Zeneng, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qvo5doq315j284u0kfng6qfg02